文献速递乳腺USMR

整合超声与多序列MRI的深度学习影像组学列线图对接受新辅助化疗的三阴性乳腺癌的预后价值

Prognostic Utility of a Deep Learning Radiomics Nomogram Integrating Ultrasound and Multi-Sequence MRI in Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.
PubMed 文献 · J Ultrasound Med · 2025-09-08

回顾性多中心研究纳入四家机构103例经病理确诊的三阴性乳腺癌患者,训练组72例来自连云港市第一人民医院,验证组31例来自三家外部中心,从二维超声和三维MRI提取影像组学特征构建深度学习影像组学列线图(DLRN),该模型对无病生存期预测的C指数为0.859-0.887,对总生存期预测的C指数为0.800-0.811。

要点

  • DLRN模型对无病生存期预测的C指数为0.859-0.887,优于其他模型。
  • DLRN模型对总生存期预测的C指数为0.800-0.811,略低于MRI+US联合影像组学模型。
  • 低风险组3年复发转移率21.43-35.71%,显著低于高风险组的77.27-82.35%。

核心结论

  • 术前DLRN模型整合超声与多序列MRI,有望作为接受新辅助化疗的三阴性乳腺癌患者复发、转移和生存结局的预后工具,其风险评分可能有助于个体化预后评估和术前风险分层。

研究设计与样本

  • 回顾性多中心研究,纳入四家机构103例经组织病理学确诊的三阴性乳腺癌患者,训练组72例来自连云港市第一人民医院,验证组31例来自三家外部中心,从二维超声和三维MRI图像分割后提取影像组学特征构建DLRN模型,以C指数评估预后性能并与替代建模方法比较。

诊断标准与关键数值

  • DLRN模型对无病生存期预测的C指数为0.859-0.887,对总生存期预测的C指数为0.800-0.811;无病生存期预测中DLRN模型优于其他模型,总生存期预测中DLRN模型略低于MRI+US联合影像组学模型;低风险组3年复发转移率为21.43-35.71%,高风险组为77.27-82.35%。

临床应用与阅片要点

  • 作者认为术前DLRN模型有望作为接受新辅助化疗的三阴性乳腺癌患者复发、转移和生存结局的预后工具,其风险评分可能有助于个体化预后评估和术前风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study is to evaluate the prognostic performance of a nomogram integrating clinical parameters with deep learning radiomics (DLRN) features derived from ultrasound and multi-sequence magnetic resonance imaging (MRI) for predicting survival, recurrence, and metastasis in patients diagnosed with triple-negative breast cancer (TNBC) undergoing neoadjuvant chemotherapy (NAC).

METHODS: This retrospective, multicenter study included 103 patients with histopathologically confirmed TNBC across four institutions. The training group comprised 72 cases from the First People's Hospital of Lianyungang, while the validation group included 31 cases from three external centers. Clinical and follow-up data were collected to assess prognostic outcomes. Radiomics features were extracted from two-dimensional ultrasound and three-dimensional MRI images following image segmentation. A DLRN model was developed, and its prognostic performance was evaluated using the concordance index (C-index) in comparison with alternative modeling approaches. Risk stratification for postoperative recurrence was subsequently performed, and recurrence and metastasis rates were compared between low- and high-risk groups.

RESULTS: The DLRN model demonstrated strong predictive capability for DFS (C-index: 0.859-0.887) and moderate performance for overall survival (OS) (C-index: 0.800-0.811). For DFS prediction, the DLRN model outperformed other models, whereas its performance in predicting OS was slightly lower than that of the combined MRI + US radiomics model. The 3-year recurrence and metastasis rates were significantly lower in the low-risk group than in the high-risk group (21.43-35.71% vs 77.27-82.35%).

CONCLUSION: The preoperative DLRN model, integrating ultrasound and multi-sequence MRI, shows promise as a prognostic tool for recurrence, metastasis, and survival outcomes in patients with TNBC undergoing NAC. The derived risk score may facilitate individualized prognostic evaluation and aid in preoperative risk stratification within clinical settings.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Cheng C, Peng X, Sang K, et al. Prognostic Utility of a Deep Learning Radiomics Nomogram Integrating Ultrasound and Multi-Sequence MRI in Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy. J Ultrasound Med. 2025. PMID: 40920176. doi:10.1002/jum.70054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。